 HOLLISTON, Mass., Dec. 22, 2020 GLOBE NEWSWIRE -- Harvard Bioscience, Inc. Nasdaq: HBIO Harvard Bioscience today announced the refinancing of its debt with the closing of a new 65 million credit facility the Refinancing. Proceeds from the new facility will be used to retire existing debt and pay related fees and expenses. The Refinancing significantly reduces borrowing costs while increasing operating flexibility through less restrictive financial covenants and access to higher levels of revolver borrowings. 